Jessica Linden
Papers
1
Total Citations
2
H-Index
1
About
Jessica Linden is a clinical researcher whose work focuses on improving cancer staging accuracy and its impact on patient outcomes. Her most cited paper, "Inaccurate Clinical Stage Is Common and Associated With Poor Survival in Patients With Lung Cancer" (2024), highlights a critical gap in oncology: the frequent misclassification of disease stage at diagnosis, which directly correlates with poorer survival rates. With 2 citations in its early publication, this study underscores her contribution to identifying systemic flaws in staging protocols and advocating for more precise diagnostic tools. Linden’s research bridges clinical practice and patient-centered care, emphasizing how staging errors can lead to suboptimal treatment decisions. Her work has implications for refining staging guidelines and integrating advanced imaging or molecular markers to reduce inaccuracies. While early in her career, Linden’s findings resonate with oncologists and health systems striving to improve lung cancer prognosis. By exposing the prevalence and consequences of staging errors, she has laid groundwork for future studies on survival disparities and quality-of-life outcomes. Her research serves as a call to action for clinicians to reassess staging methodologies, ultimately aiming to enhance therapeutic strategies and patient survival in lung cancer.
Research Focus
Key Achievements
Top Papers
- 1